Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026
      Bank of England

      Prudential Regulation Authority Publishes New Funded Reinsurance Regulations

      April 29, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      CHIP Mortgage Trust Issues C$200m of Medium-Term Notes

      April 29, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Increased Activity In Smaller Face Value Life Settlements A Welcome Development

    Secondary Life Markets June 14, 2023By Anna Bailey
    Deal Activity
    Share
    Twitter LinkedIn Email

    Investors in the life settlement industry’s secondary market work with a provider to source policies; indeed, most states that have a regulatory regime for the asset class require a life settlement provider to be involved in the transaction. Those providers in turn source their policies either through the ‘direct to consumer’ channel – so, advertising on television, radio, in newspapers, or online – or through brokers who sell an insured’s life insurance policy on their behalf.

    A characteristic of the policies that the brokers work with is that they tend to be higher face value, and for good reason: the broker’s costs to source medical records, pay for life expectancy reports and have the insured and beneficiaries sign off on documents necessary to bring the policy to market are similar regardless of whether they’re working with a $100,000 policy or a $1million policy.

    That means that deal flow in the smaller face value end of the market from brokers has been slower. But the increase in secondary market deal flow from the direct-to-consumer channel generally in recent years has brought with it a notable increase in the volume of smaller face value policies available to life settlement investors.

    Smaller face value policies offer a range of benefits to both fund managers and end investors alike. The first benefit is the classic ‘free lunch’ – namely, diversification. Best practices in life settlements portfolio construction sees the investor diversify by gender, by age, by carrier exposure, by life expectancy, by impairments, and by state, for legal risk reasons. Many funds in our market are closed ended, so a finite amount of capital goes further from a diversification perspective by investing in smaller face policies, as more policies make it into the portfolio. Instead of buying five large face policies with high-cost premiums, one could arguably purchase 25 polices with the same amount of capital with lower premiums and a diverse pool.

    The second benefit is in being able to execute the job we are supposed to do. Portfolio managers are paid to (wisely) deploy their client’s capital. The life settlement industry’s tertiary market already provides a mechanism to allocate larger amounts of money, but in the secondary market, there is less activity in the smaller face end, so there’s less likelihood of delayed deployment.

    The third benefit is access to a part of the market which is growing. ‘Baby boomers’ are now entering the life settlement market in the sense that many of them are now of an age where they might consider selling their policy. These seniors are more internet savvy than their predecessors – the ‘Silent Generation’ – and because of this, they have more access to information which in turn means that more of them are familiar with the life settlement option (far too many American Seniors are still unaware of the option that the life settlement industry presents to them) to access liquidity. Again, this trend will fuel increased activity in the direct-to-consumer channel.

    Larger face value policies are owned by high-net-worth individuals, the healthy, wealthy, ‘1%’ of the population. The life expectancy profile of these insureds does not always align consistently with the 2015 Valuation Basic Tables used by the life insurance industry for modelling life expectancy because they have a different life expectancy profile; they typically live longer than the ‘average’ person. But the life expectancy of individuals holding smaller face value policies do align with the 2015 VBT, which, for an investor, means that our exposure to valuation risk is lower.

    Life settlement investors that previously focused heavily or exclusively on larger face value policies are increasingly paying attention to the lower end of the market. The ability to buy more policies with a finite amount of capital not only supports diversification, but volatility and cash flow within the portfolio. Smaller face value policies perform because you can more easily ladder the maturities over the life of a fund which leads to more predictable cash flows from policy maturities. This is a particular benefit to an open-ended fund structure. In larger face, it’s not uncommon to have a quiet six or twelve – even more – months, where no maturities are realised, but the premiums still need to be paid.

    Increased supply of policies in the secondary market is good for our industry, regardless of the policy value size. But the smaller face value end of the market is set to be a more significant contributor to that growth in the coming years. Portfolio manager interest is shifting from buying only larger face to actively seeking out good smaller face deals, which brings with it numerous benefits, as outlined above. It’s a benefit to our entire industry – asset managers, service providers, and of course, the end investor – that activity in the smaller face value end of the market is increasing.

    Anna Bailey is Managing Partner at Chestnut Capital Management


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association.

    2023 - June Commentary Life Settlements Longevity Risk Volume 2 Issue 6 - June 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Just Group

    Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

    May 11, 2026By LMI Newsdesk

    UK Equity Release Market Origination Slows To Begin 2026

    May 6, 2026By LMI Newsdesk
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.